[A21-37] Development of a scientific concept for the generation of routine practice data and their analysis for benefit assessments according to §35a Social Code Book (SGB) V in the event of market access for several drugs of one drug class

Project no.:
A21-37

Commission:
Commission awarded on 01.04.2021 by the Federal Joint Committee (G-BA).

Report type:
Rapid report

Status:
Commission completed

Department/Division:
Drug Assessment

Topic:
Haematology

27.05.2022

The Institute recommends platform studies under a master protocol

Press release

Extract of the rapid report: Development of a scientific concept for the generation of routine practice data according to the Law for More Safety in the Supply of Medicines (GSAV) and their analysis for benefit assessments according to §35a Social Code Book (SGB) V in the event of market access for several drugs of one drug class

DE, PDF, 261 kB, PDF

published on May 27, 2022
Rapid Report: Development of a scientific concept for the generation of routine practice data according to the Law for More Safety in the Supply of Medicines (GSAV) and their analysis for benefit assessments according to §35a Social Code Book (SGB) V in the event of market access for several drugs of one drug class

DE, PDF, 968 kB, PDF

published on May 27, 2022

Contact